Patterns of Impaired Neurocognitive Performance on the Global Neuropsychological Assessment, and Their Brain Structural Correlates in Recent-onset and Chronic Schizophrenia

키워드

참고문헌 (121)

1. Albus M, "Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 15-year follow-up study", Eur Arch Psychiatry Clin Neurosci, 270, pp.689~698 (2020)
2. Adarsh Tripathi, "Cognitive Deficits in Schizophrenia: Understanding the Biological Correlates and Remediation Strategies", Clinical Psychopharmacology and Neuroscience, 16(1), pp.7~17 (2018), 대한정신약물학회[DOI]
3. McCleery A, "Cognitive impairment in psychotic illness : prevalence, profile of impairment, developmental course, and treatment considerations", Dialogues Clin Neurosci, 21, pp.239~248 (2019)
4. Zhang H, "Meta-analysis of cognitive function in Chinese first-episode schizophrenia : MATRICS Consensus Cognitive Battery(MCCB)profile of impairment", Gen Psychiatr, 32, pp.e100043~ (2019)
5. Mesholam-Gately RI, "Neurocognition in first-episode schizophrenia : a meta-analytic review", Neuropsychology, 23, pp.315~336 (2009)
6. Fusar-Poli P, "Cognitive functioning in prodromal psychosis : a meta-analysis", Arch Gen Psychiatry, 69, pp.562~571 (2012)
7. Zhang T, "Neuropsychological impairment in prodromal, first-episode, and chronic psychosis : assessing RBANS performance", PLoS One, 10, pp.e0125784~ (2015)
8. Chu AOK, "Comparison of cognitive functions between first-episode schizophrenia patients, their unaffected siblings and individuals at clinical high-risk for psychosis", Psychol Med, 49, pp.1929~1936 (2019)
9. Keshavan MS, "Premorbid cognitive deficits in young relatives of schizophrenia patients", Front Hum Neurosci, 3, pp.62~ (2010)
10. Greenwood TA, "Endophenotypes in schizophrenia : digging deeper to identify genetic mechanisms", J Psychiatr Brain Sci, 4, pp.e190005~ (2019)
11. Kelly S, "Neural correlates of cognitive deficits across developmental phases of schizophrenia", Neurobiol Dis, 131, pp.104353~ (2019)
12. Liu Y, "Cognitive deficits in subjects at risk for psychosis, first-episode and chronic schizophrenia patients", Psychiatry Res, 274, pp.235~242 (2019)
13. Kurtz MM, "Neurocognitive impairment across the lifespan in schizophrenia : an update", Schizophr Res, 74, pp.15~26 (2005)
14. Nemoto T, "Long-term course of cognitive function in chronically hospitalized patients with schizophrenia transitioning to community-based living", Schizophr Res, 155, pp.90~95 (2014)
15. Sponheim SR, "Cognitive deficits in recent-onset and chronic schizophrenia", J Psychiatr Res, 44, pp.421~428 (2010)
16. Zanelli J, "Cognitive change in schizophrenia and other psychoses in the decade following the first episode", Am J Psychiatry, 176, pp.811~819 (2019)
17. Bonner-Jackson A, "Neurocognition in schizophrenia : a 20-year multi-follow-up of the course of processing speed and stored knowledge", Compr Psychiatry, 51, pp.471~479 (2010)
18. Andreasen NC, "Progressive brain change in schizophrenia : a prospective longitudinal study of first-episode schizophrenia", Biol Psychiatry, 70, pp.672~679 (2011)
19. Fett AJ, "Long-term changes in cognitive functioning in individuals with psychotic disorders : findings from the Suffolk County Mental Health Project", JAMA Psychiatry, 77, pp.387~396 (2020)
20. Harvey PD, "Cognitive impairment in schizophrenia: characteristics, assessment and treatment", pp.324~ (2013), Cambridge University Press
21. Keefe RS, "The Brief Assessment of Cognition in Schizophrenia : reliability, sensitivity, and comparison with a standard neurocognitive battery", Schizophr Res, 68, pp.283~297 (2004)
22. Pietrzak RH, "A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia(MATRICS)Battery in assessing cognitive impairment in chronic schizophrenia", J Clin Exp Neuropsychol, 31, pp.848~859 (2009)
23. Hill SK, "Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia", J Int Neuropsychol Soc, 14, pp.209~221 (2008)
24. Keefe R, "Guide to assessment scales in schizophrenia", pp.92~ (2013), Science+Business Media
25. Irani F, "Computerized neurocognitive test performance in schizophrenia : a lifespan analysis", Am J Geriatr Psychiatry, 20, pp.41~52 (2012)
26. "GNI" (2018)[URL]
27. Olson LT, "Preliminary validation of the Global Neuropsychological Assessment in Alzheimer’s disease and healthy volunteers", Assessment, 29, pp.817~825 (2022)
28. Smerbeck A, "Effects of repeated administration and comparability of alternate forms for the Global Neuropsychological Assessment(GNA)", Assessment (2021)[DOI]
29. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Association
30. First M, "Structured clinical interview for DSM-5 disorders (Scid-5-cv): clinician version" (2016), American Psychiatric Association
31. World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects", JAMA, 310, pp.2191~2194 (2013)
32. Oldfield RC, "The assessment and analysis of handedness : the Edinburgh inventory", Neuropsychologia, 9, pp.97~113 (1971)
33. Haddock G, "Scales to measure dimensions of hallucinations and delusions : the psychotic symptom rating scales(PSYRATS)", Psychol Med, 29, pp.879~889 (1999)
34. Andreasen NC, "The Scale for the Assessment of Negative Symptoms (SANS)", The University of Iowa, ~ (1983)
35. Andreasen NC, "The Scale for the Assessment of Negative Symptoms (SANS)", The University of Iowa, ~ (1984)
36. Guy W, "Abnormal involuntary movement scale: ECDEU assessment manual for psychopharmacology", U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 612~ (1976)
37. Simpson GM, "A rating scale for extrapyramidal side effects", Acta Psychiatr Scand Suppl, 212, pp.11~19 (1970)
38. Barnes TR, "A rating scale for drug-induced akathisia", Br J Psychiatry, 154, pp.672~676 (1989)
39. Leucht S, "Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia", Am J Psychiatry, 177, pp.342~353 (2020)
40. Leucht S, "Dose equivalents for antipsychotic drugs : the DDD method", Schizophr Bull, 42(Suppl 1), pp.S90~S94 (2016)
41. Anda L, "Cognitive profile in ultra high risk for psychosis and schizophrenia : a comparison using coordinated norms", Front Psychiatry, 10, pp.695~ (2019)
42. van Erp TG, "Neuropsychological profile in adult schizophrenia measured with the CMINDS", Psychiatry Res, 230, pp.826~834 (2015)
43. "RStudio | Open source & professional software for data science teams" (2020)[URL]
44. Parekh P, "Protocol for magnetic resonance imaging acquisition, quality assurance, and quality check for the Accelerator program for Discovery in Brain disorders using Stem cells", Int J Methods Psychiatr Res, 30, pp.e1871~ (2021)
45. Ardekani BA, "A new approach to symmetric registration of longitudinal structural MRI of the human brain", J Neurosci Methods, 373, pp.109563~ (2022)
46. Ardekani BA, "Automatic detection of the mid-sagittal plane in 3-D brain images", IEEE Trans Med Imaging, 16, pp.947~952 (1997)
47. Ardekani BA, "Model-based automatic detection of the anterior and posterior commissures on MRI scans", Neuroimage, 46, pp.677~682 (2009)
48. Gaser C, "CAT-a computational anatomy toolbox for the analysis of structural MRI data", HBM, 2016, pp.336~348 (2016)
49. Ben-Shachar MS, "effectsize : estimation of effect size indices and standardized parameters", J Open Source Softw, 5, pp.2815~ (2020)
50. "Why Hedges’ g*s based on the non-pooled standard deviation should be reported with Welch’s t-test" (2021)[URL]
51. Hedges LV, "Distribution theory for Glass’s estimator of effect size and related estimators", J Educ Stat, 6, pp.107~128 (1981)
52. Cohen J, "Statistical power analysis for the behavioral sciences", pp.567~ (1988), Routledge
53. Lakens D, "Calculating and reporting effect sizes to facilitate cumulative science : a practical primer for t-tests and ANOVAs", Front Psychol, 4, pp.863~ (2013)
54. Korkmaz S, "MVN : an R package for assessing multivariate normality", R Journal, 6, pp.151~162 (2014)
55. Smith SM, "Threshold-free cluster enhancement : addressing problems of smoothing, threshold dependence and localisation in cluster inference", Neuroimage, 44, pp.83~98 (2009)
56. Tabachnick BG, "Using multivariate statistics", pp.2007, Allyn & Bacon
57. Clason DL, "Adjusted means in analysis of covariance : are they meaningful?", Mult Linear Regres Viewp, 38, pp.8~15 (2012)
58. Dorofeikova M, "Cognitive deficit in patients with paranoid schizophrenia : Its clinical and laboratory correlates", Psychiatry Res, 262, pp.542~548 (2018)
59. Rajji TK, "Age at onset and cognition in schizophrenia : meta-analysis", Br J Psychiatry, 195, pp.286~293 (2009)
60. Dragovic M, "Do the generalised cognitive deficits observed in schizophrenia indicate a rapidly-ageing brain?", Eur J Psychiatry, 30, pp.141~148 (2016)
61. Andersen R, "The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients", Eur Psychiatry, 28, pp.332~339 (2013)
62. 김문두, "The Relationship between Cognitive Decline and Psychopathology in Patients with Schizophrenia and Bipolar Disorder", Clinical Psychopharmacology and Neuroscience, 13(1), pp.103~108 (2015), 대한정신약물학회
63. Dickinson D, "General and specific cognitive deficits in schizophrenia : Goliath defeats David?", Biol Psychiatry, 64, pp.823~827 (2008)
64. John JP, "Regional brain activation", deactivation during word generation in schizophrenia : fMRI study, 2011, pp.198, 213~222
65. Szöke A, "Longitudinal studies of cognition in schizophrenia : meta-analysis", Br J Psychiatry, 192, pp.248~257 (2008)
66. 김도훈, "Shared and Distinct Neurocognitive Endophenotypes of Schizophrenia and Psychotic Bipolar Disorder", Clinical Psychopharmacology and Neuroscience, 13(1), pp.94~102 (2015), 대한정신약물학회
67. Shao Z, "What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults", Front Psychol, 5, pp.772~ (2014)
68. Elgamal SA, "Age and verbal fluency : the mediating effect of speed of processing", Can Geriatr J, 14, pp.66~72 (2011)
69. Salthouse TA, "Trajectories of normal cognitive aging", Psychol Aging, 34, pp.17~24 (2019)
70. Murman DL, "The impact of age on cognition", Semin Hear, 36, pp.111~121 (2015)
71. Salthouse T, "Major issues in cognitive aging", pp.257~ (2010), Oxford University Press
72. Hulshoff Pol HE, "What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia", Schizophr Bull, 34, pp.354~366 (2008)
73. Olabi B, "Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies", Biol Psychiatry, 70, pp.88~96 (2011)
74. Kirkpatrick B, "Accelerated aging in schizophrenia and related disorders : future research", Schizophr Res, 196, pp.4~8 (2018)
75. Schnack HG, "Accelerated brain aging in schizophrenia : a longitudinal pattern recognition study", Am J Psychiatry, 173, pp.607~616 (2016)
76. Lee J, "The effects of age and sex on cognitive impairment in schizophrenia : findings from the Consortium on the Genetics of Schizophrenia(COGS)study", PLoS One, 15, pp.e0232855~ (2020)
77. Cargin JW, "Decline in verbal memory in non-demented older adults", J Clin Exp Neuropsychol, 29, pp.706~718 (2007)
78. Zaninotto P, "Cognitive function trajectories and their determinants in older people : 8 years of follow-up in the English Longitudinal Study of Ageing", J Epidemiol Community Health, 72, pp.685~694 (2018)
79. Brickman AM, "Encyclopedia of neuroscience", pp.175~180 (2009), Elsevier
80. Harada CN, "Normal cognitive aging", Clin Geriatr Med, 29, pp.737~752 (2013)
81. Bastin C, "Early neuropsychological detection of Alzheimer’s disease", Eur J Clin Nutr, 68, pp.1192~1199 (2014)
82. Constantinidou F, "Age-related decline in verbal learning is moderated by demographic factors, working memory capacity, and presence of amnestic mild cognitive impairment", J Int Neuropsychol Soc, 20, pp.822~835 (2014)
83. Lange KL, "Decline in verbal memory during preclinical Alzheimer’s disease : examination of the effect of APOE genotype", J Int Neuropsychol Soc, 8, pp.943~955 (2002)
84. Tabert MH, "Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment", Arch Gen Psychiatry, 63, pp.916~924 (2006)
85. Fjell AM, "Critical ages in the life course of the adult brain : nonlinear subcortical aging", Neurobiol Aging, 34, pp.2239~2247 (2013)
86. "Tutorial: power analyses for interaction effects in cross-sectional regressions" (2022)[URL]
87. Heo M, "Sample sizes required to detect two-way and three-way interactions involving slope differences in mixed-effects linear models", J Biopharm Stat, 20, pp.787~802 (2010)
88. Bobilev AM, "Molecular alterations in the medial temporal lobe in schizophrenia", Schizophr Res, 217, pp.71~85 (2020)
89. DeRamus TP, "Covarying structural alterations in laterality of the temporal lobe in schizophrenia : a case for source-based laterality", NMR Biomed, 33, pp.e4294~ (2020)
90. Kaur A, "Structural and functional alterations of the temporal lobe in schizophrenia : a literature review", Cureus, 12, pp.e11177~ (2020)
91. Lambon Ralph MA, "Coherent concepts are computed in the anterior temporal lobes", Proc Natl Acad Sci U S A, 107, pp.2717~2722 (2010)
92. Bonner MF, "Where is the anterior temporal lobe and what does it do?", J Neurosci, 33, pp.4213~4215 (2013)
93. Patterson K, "Neurobiology of language", pp.765~775 (2016), Elsevier
94. Pobric G, "Anterior temporal lobes mediate semantic representation : mimicking semantic dementia by using rTMS in normal participants", Proc Natl Acad Sci U S A, 104, pp.20137~20141 (2007)
95. Woollams AM, "Laterality of anterior temporal lobe repetitive transcranial magnetic stimulation determines the degree of disruption in picture naming", Brain Struct Funct, 222, pp.3749~3759 (2017)
96. Moscovitch M, "Episodic memory and beyond : the hippocampus and neocortex in transformation", Annu Rev Psychol, 67, pp.105~134 (2016)
97. Bonnen T, "When the ventral visual stream is not enough : a deep learning account of medial temporal lobe involvement in perception", Neuron, 109, pp.2755~2766 (2021)
98. Lawrence AV, "Medial temporal lobe regions mediate complex visual discriminations for both objects and scenes : a process-based view", Hippocampus, 30, pp.879~891 (2020)
99. Lech RK, "Involvement of the human medial temporal lobe in a visual discrimination task", Behav Brain Res, 268, pp.22~30 (2014)
100. Baddeley A, "Working memory : looking back and looking forward", Nat Rev Neurosci, 4, pp.829~839 (2003)
101. Geva S, "Lesions that do or do not impair digit span : a study of 816 stroke survivors", Brain Commun, 3, pp.fcab031~ (2021)
102. Koenigs M, "Areas of left perisylvian cortex mediate auditory-verbal short-term memory", Neuropsychologia, 49, pp.3612~3619 (2011)
103. Papagno C, "Mapping the brain network of the phonological loop", Hum Brain Mapp, 38, pp.3011~3024 (2017)
104. Carpenter AF, "Encoding of serial order in working memory : neuronal activity in motor, premotor, and prefrontal cortex during a memory scanning task", J Neurosci, 38, pp.4912~4933 (2018)
105. Kambara T, "Neural dynamics of verbal working memory in auditory description naming", Sci Rep, 8, pp.15868~ (2018)
106. Javitt DC, "Auditory dysfunction in schizophrenia : integrating clinical and basic features", Nat Rev Neurosci, 16, pp.535~550 (2015)
107. John JP, "Self, culture and consciousness: interdisciplinary convergences on knowing and being", pp.123~149 (2017), Springer Singapore
108. Jong-Hoon Kim, "Neural Signature for Auditory Hallucinations in Schizophrenia: A High-Resolution Positron Emission Tomography Study with Fludeoxyglucose (18F)", Clinical Psychopharmacology and Neuroscience, 16(3), pp.324~332 (2018), 대한정신약물학회[DOI]
109. Marder SR, "The current conceptualization of negative symptoms in schizophrenia", World Psychiatry, 16, pp.14~24 (2017)
110. Strassnig M, "Which levels of cognitive impairments and negative symptoms are related to functional deficits in schizophrenia?", J Psychiatr Res, 104, pp.124~129 (2018)
111. Moritz S, "Much of the neurocognitive impairment in schizophrenia is due to factors other than schizophrenia itself : implications for research and treatment", Schizophr Bull Open, 2, pp.sgaa034~ (2021)
112. Ang MS, "The impact of medication anticholinergic burden on cognitive performance in people with schizophrenia", J Clin Psychopharmacol, 37, pp.651~656 (2017)
113. Frydecka D, "Profiling cognitive impairment in treatment-resistant schizophrenia patients", Psychiatry Res, 235, pp.133~138 (2016)
114. Caligiuri MP, "The nature of bradykinesia in schizophrenia treated with antipsychotics", Psychiatry Res, 273, pp.537~543 (2019)
115. Knowles EE, "Processing speed deficits in schizophrenia : reexamining the evidence", Am J Psychiatry, 167, pp.828~835 (2010)
116. Emsley R, "The evidence for illness progression after relapse in schizophrenia", Schizophr Res, 148, pp.117~121 (2013)
117. Nuechterlein KH, "The MATRICS consensus cognitive battery, part 1 : test selection, reliability, and validity", Am J Psychiatry, 165, pp.203~213 (2008)
118. Reynolds G, "Predictors of residency status in chronically institutionalized and community dwelling schizophrenia patients", Compr Psychiatry, 86, pp.102~106 (2018)
119. Murante T, "Cognitive functioning in older adults with schizophrenia", Focus(Am Psychiatr Publ), 15, pp.26~34 (2017)
120. Kline E, "A comparison of neurocognition and functioning in first episode psychosis populations : do research samples reflect the real world?", Soc Psychiatry Psychiatr Epidemiol, 54, pp.291~301 (2019)
121. Immonen J, "Age at onset and the outcomes of schizophrenia : a systematic review and meta-analysis", Early Interv Psychiatry, 11, pp.453~460 (2017)

관련 논문AI추천